Harbin First Pharmaceutical

Harbin First Pharmaceutical, a core subsidiary of the Harbin Pharmaceutical Group (Hayao), is a major Chinese pharmaceutical manufacturer based in Heilongjiang province. The company specializes in the production of traditional Chinese medicines (TCM), chemical generics, and high-volume injectable formulations. It is particularly well-known for its flagship product, Shuanghuanglian, which is widely used in China for treating respiratory infections. The company operates large-scale, GMP-certified manufacturing facilities that supply both domestic and international markets with antibiotics, cardiovascular drugs, and nutritional supplements. As a key player in the Chinese healthcare sector, it integrates traditional herbal expertise with modern chemical synthesis and sterile manufacturing processes.